{"id":"NCT02195479","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma","officialTitle":"A Phase 3, Randomized, Controlled, Open-label Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-09","primaryCompletion":"2017-11-21","completion":"2024-08-07","firstPosted":"2014-07-21","resultsPosted":"2018-12-17","lastUpdate":"2025-08-22"},"enrollment":706,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Velcade","otherNames":[]},{"type":"DRUG","name":"Melphalan","otherNames":[]},{"type":"DRUG","name":"Prednisone","otherNames":[]},{"type":"DRUG","name":"Daratumumab IV","otherNames":[]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"Daratumumab SC","otherNames":[]}],"arms":[{"label":"Treatment Arm A (VMP Alone)","type":"ACTIVE_COMPARATOR"},{"label":"Treatment Arm B (D-VMP)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine if the addition of daratumumab to velcade (bortezomib) melphalan-prednisone (VMP) will prolong progression-free survival (PFS) compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy and autologous stem cell transplant (ASCT).","primaryOutcome":{"measure":"Progression Free Survival (PFS)","timeFrame":"From randomization (Day -3) up to 2.4 years","effectByArm":[{"arm":"Velcade, Melphalan and Prednisone (VMP)","deltaMin":18.14,"sd":null},{"arm":"Daratumumab, Velcade, Melphalan and Prednisone (D-VMP)","deltaMin":null,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":160,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Croatia","Czechia","Georgia","Germany","Greece","Hungary","Japan","North Macedonia","Poland","Portugal","Romania","Russia","Serbia","South Korea","Spain","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40220771","34344638","34289038","34269818","34078314","31836199","29231133"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":117,"n":354},"commonTop":["Thrombocytopenia","Neutropenia","Anaemia","Peripheral Sensory Neuropathy","Diarrhoea"]}}